A carregar...
Recombinant human factor VIIa (rFVIIa) in hemophilia: mode of action and evidence to date
Recombinant activated factor VII (rFVIIa) is a bypassing agent widely used both in the treatment and prevention of hemorrhagic complications due to hemophilia with inhibitor. In such cases, antihemophilic factors cannot be used. The normal physiology of factor VII/ factor VIIa (FVII/FVIIa) in the he...
Na minha lista:
| Publicado no: | Ther Adv Hematol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5703115/ https://ncbi.nlm.nih.gov/pubmed/29204261 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620717737701 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|